STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 89 filers reported holding STOKE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $128,629 | -62.7% | 32,647 | +0.5% | 0.00% | -66.7% |
Q2 2023 | $345,284 | +42.5% | 32,482 | +11.7% | 0.00% | +50.0% |
Q1 2023 | $242,278 | -1.9% | 29,085 | +8.7% | 0.00% | 0.0% |
Q4 2022 | $246,893 | -10.5% | 26,749 | +24.3% | 0.00% | -33.3% |
Q3 2022 | $276,000 | -10.1% | 21,515 | -7.4% | 0.00% | 0.0% |
Q2 2022 | $307,000 | -62.0% | 23,245 | -39.5% | 0.00% | -66.7% |
Q1 2022 | $808,000 | -20.9% | 38,393 | -9.8% | 0.01% | -18.2% |
Q4 2021 | $1,021,000 | -10.9% | 42,571 | -5.5% | 0.01% | 0.0% |
Q3 2021 | $1,146,000 | -29.6% | 45,034 | -6.9% | 0.01% | -21.4% |
Q2 2021 | $1,627,000 | – | 48,351 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |